HanAll Biopharma (KRX: 009420.KS) is a global biopharmaceutical company with a presence in Korea, the USA, Japan, and Indonesia, with a mission to make meaningful contributions to patients' lives by introducing innovative, impactful medicines to address severe unmet medical needs. HanAll has been operating a portfolio of pharmaceutical products in areas ranging from endocrine, circulatory, and urologic diseases for 50 years.
HanAll has also expanded its focus to ophthalmology, immunology, oncology, and neurology to discover and develop innovative medicines for patients with diseases for which there are no effective treatments. Its lead pipeline asset, HL161 (INN: batoclimab), an anti-FcRn antibody, is being developed in Phase 3 and Phase 2 trials worldwide for the treatment of autoimmune diseases, including myasthenia gravis (MG), thyroid eye disease (TED), chronic inflammatory demyelinating polyneuropathy (CIDP), and Graves’ disease (GD). Another key asset, HL036 (INN: tanfanercept), a TNF-alpha inhibitor protein, is being evaluated in Phase 3 clinical studies in the US and China for the treatment of dry eye disease.
Company Details
- Employees
- 52
- Founded
- -
- Address
- 12 Bongeunsa-Ro 114-Gil, Daewoong Building 3f,korea, Republic Of
- Phone
- 306-81-05479
- in****@****l.co.kr
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- hanall.com
- Keywords
- Innovation, Novel biologic drugs, R&D.
- HQ
- Seoul, Gangam-gu
Hanall Biopharma Questions
Hanall Biopharma's helpline number is 306-81-05479
Hanall Biopharma's website is hanall.com
Hanall Biopharma's LinkedIn profile is https://www.linkedin.com/company/hanall
Hanall Biopharma has
52 employees.
View email and phone details for 52
employees at Hanall Biopharma.
Hanall Biopharma's industry is
Biotechnology Research
Hanall Biopharma's top competitors are
Shiftbio Inc.,
Sk Biopharmaceuticals,
Hlb Pharma Group,
Immunovant,
Merit Cro,
Pt. Infion Pharmaceutical Company,
Daewoong Pharmaceutical,
Viridian Therapeutics, Inc.,
Imnewrun,
Turn Biotechnologies.
Hanall Biopharma's support email address is ineffable@hanall.co.kr
Hanall Biopharma's categories are Biotechnology Research
Hanall Biopharma's founding year is 1973
